octobre 2019

BioNTech SE

BioNTech SE

Joint Bookrunner (IPO)

More Like This

US$29m

septembre 2025

Lucid Diagnostics

Joint Bookrunner (Follow-On Offering)
US$637m

septembre 2025

Vitruvian Partners

Advisor to Vitruvian Partners on its $637 Million Investment in DeepIntent
US$364m

août 2025

Heartflow

Co-Manager (IPO)

Afficher les transactions Healthcare